The ICD-11 For the Twenty-First Century: The First View from The Organizational, Legal, Clinical and Pharmacological Aspects
DOI:
https://doi.org/10.53933/sspmpm.v2i1.37Keywords:
ICD-11, classification of diseases, psychoactive substances, mental and behavioral health disorders, clinical pharmacy, organization and management of pharmacyAbstract
The author made an organizational and legal, clinical and pharmacological study of the latest International Classification of Diseases (ICD-11) concerning its changes compared to the ICD-10. Particular attention was paid to new ways of marking of disease codes and new functions of the ICD-11. Novel structure based on cluster coding, which was implemented into the new revision was mentioned, which allows to connect the main diagnostic codes with advanced clinical indicators. Author found that for the first time, the new revision has become a fully electronic publication that provides access to more than 17,000 diagnostic categories that contain more than hundred thousand of terms of the medical diagnostic index. The new ICD-11 concept of linearization for the national needs of each country was taken into account, which will save budget expenditures for the future. In the new edition of the ICD-11, for the first time, gambling addiction is classified as a mental disorder – behavioral addiction to online and offline gambling. The list of ICD-11 short stories also includes the classification of the following: chronic pain, burnout, stroke, sexual health, post-traumatic stress disorder, allergies, alternative medicine, etc. It is a more powerful health information system based on a formal ontology, designed to integrate information technology into modern infrastructures. A comparison with the ICD-10 on mental and behavioral disorders due to the use of psychoactive substances was made. The ICD-11 has been identified as having a more comprehensive list of disease diagnosis codes, and in the ICD-10 the section on mental and behavioral disorders due to substance use has eleven core codes. Indicated the prospects of using of the ICD-11 in medical practice.
References
Occupational burnout is a phenomenon, not a disease: What was actually approved in ICD-11. Ministry of Health of Ukraine. URL: https://moz.gov.ua/article/news/profesijne-vigorannja---javische-a-ne-hvoroba-scho-naspravdi-zatverdili-v-mkh-11.
Occupational burnout is considered a syndrome, and gaming addiction is considered a disease. LexInform. URL: https://lexinform.com.ua/zakonodavstvo/profesijne-vygorannya-vyznayut-syndromom-a-igrovu-zalezhnist-hvoroboyu/
Krasnov V.N. ICD-11 as a Paradigm Shift Phase in the Classification of Mental Disorders. Consortium Psychiatricum. 2021. Vol. 2. Issue 2. P. 72-75. DOI:10.17816/CP70. URL: https://consortium-psy.com/jour/article/view/70 DOI: https://doi.org/10.17816/CP70
Reed G.M., First M.B., Kogan C.S. et al. Innovations and changes in the ICD‐11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry., 02.01.2019. Vol.18. N.1. Р. 3-19. DOI: 10.1002/wps.20611. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313247/
Hayduchok I.G., Shapovalova V.O., Ishcheikin K.E. et al. Pharmaeconomic approaches for pharmacotherapy of Rheumatoid arthritis. Likars’ka Sprava. 2021. N. 1–2. P. 54-63. DOI: 10.31640/JVD.1-2.2021(8) DOI: https://doi.org/10.31640/JVD.1-2.2021(11)
Tukhar I., Shapovalova V., Shapovalov V. et al. Pharmacological view on the problem of comorbidity in the pharmacotherapy of chronic pancreatitis. Science Review. Vol. 3. No. 38. P. 1-5. DOI: 10.31435/rsglobal_sr/30072021/7591 DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7591
Chuiev Y., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.24. DOI: https://doi.org/10.53933/sspmpm.v1i2.24
Shapovalov V., Butko L., Shapovalov V. Organizational and legal study of quarantine restrictions in the spread of coronavirus disease in Ukraine. SSP Modern Pharmacy and Medicine. 2021. Vol. 1. N. 2. P. 1–12. URL: https://doi.org/10.53933/sspmpm.v1i2.23. DOI: https://doi.org/10.53933/sspmpm.v1i2.23
Shapovalova V., Shapovalov V., Shapovalov V. et al. Experience of the department of medical and pharmaceutical law, general and clinical pharmacy of the Kharkiv medical academy of postgraduate education concerning the educational process during the quarantine period caused by COVID-19. Actual Problems of Medicine and Pharmacy. 2021. Vol.2. N.2. P. 1–20. https://doi.org/10.52914/apmp.v2i2.33. DOI: https://doi.org/10.52914/apmp.v2i2.33
Hayduchok I., Shapovalov V. Forensic pharmacy and medicine: risks for pharmacotherapy of addiction and countering of illegal circulation of psychoactive substances in the COVID-19 pandemic. 2021. SSP Modern Pharmacy and Medicine. Vol. 1. N. 2. P. 1-28. URL: https://doi.org/10.53933/sspmpm.v1i2.32. DOI: https://doi.org/10.53933/sspmpm.v1i2.32
Shapovalova V.A., Zbrozhek S.I., Shapovalov V.V. et al. Forensic pharmacy: some risk factors in the formation of addictive health disorders. Acta Scientific Pharmaceutical Science. 2021. V. 4. Iss. 1. P. 7–12. DOI: 10.3180/ ASPS.2020.05.0651.
Shapovalov V. (Jr.), Gudzenko А., Komar L. et al. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017. Vol. 65. N. 2. P. 23–29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.
Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. at. el. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol. 66. N. 3. Р. 31–39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.
Zbrozhek S.I., Shapovalova V.A., Shapovalov V.V. et al. Organizational and legal research of indicators of incidence and prevalence of diabetes mellitus in countryside areas. Annals of Mechnikov Institute. 2017. N. 1. P. 44–53. URL: http://www.imiamn.org.ua/journal/1_2017/zmist1_2017.html.
Shapovalov V. (jr.), Zbrozhek S., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51. N. 1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Shapovalov V.V. (Jr.), Zbrozhek S.I., Shapovalova V.O. et al. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients Pharmacia. 2018. Vol. 65. N. 2. P. 17-22. URL: http://bsphs.org/?magasine=organizational-and-legal-evaluation-of-availability-of-medicines-circulation-for-cancer-patients.
Shapovalov V.V. Organizational and legal approaches to the development of combined drugs based on psychoactive substances for the prevention and treatment of drug addiction. Dissertation for Doctor of Pharmaceutical Sciences degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kyiv, 2005. 44 p. URL: http://irbis-nbuv.gov.ua/ASUA/0011146.
Kuznetsova T.V. Drug support for alcohol dependence therapy: dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kyiv, 2006. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0081252.
Shapovalov V.V., Gudzenko A.A., Zbrozhek S.I. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychotropic psychoactive substances in Ukraine (retrospective aspect). Annals of Mechnikov Institute. 2018. No. 3. Р. 41–44. DOI: 10.5281/zenodo.1456544. URL: http://www.imiamn.org.ua/journal/3_2018/PDF/9.pdf.
Gutorov O.I. Improving the regulatory framework for the circulation of psychoactive substances in the private sector of the regional pharmacy network. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kharkiv, 2007. 20 p. URL: http://irbis-nbuv.gov.ua/ASUA/0004817.
Bondarenko V.V. Scientific substantiation of features of expert support of circulation of psychoactive substances. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kharkiv, 2008. 22 p. URL: http://irbis-nbuv.gov.ua/ASUA/0108941.
Shapovalov V. (Jr.), Gudzneko A., Shapovalova V. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect). International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3. Is. 3. P. 22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3.
Vasina Yu.V. Organizational research of forensic pharmacy to counteract the narcotization of young people with psychoactive substances. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kharkiv, 2009. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0090297.
Osyntseva A.O. Scientific substantiation of the principles of pharmaceutical correction of polydrug addiction on the basis of forensic pharmacy. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Technology of medicines, the organization of pharmaceutical business and forensic pharmacy". Kyiv, 2020. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/1476729.
Malinina N.G. Forensic and pharmaceutical research of the control and permitting system to increase the level of state control over the circulation of precursors in Ukraine. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kharkiv, 2010. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0034175.
Petrenko V.O. Organizational and legal research of drug correction of nicotine addiction. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kharkiv, 2010. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0036699.
Kuryzheva O.O. Forensic pharmaceutical prevention of addictive addiction and drug crime among minors. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology and organization of pharmaceutical business". Kharkiv, 2011. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0048391.
Peresypkin O.V. Forensic and pharmaceutical substantiation of circulation of drugs with psychoactive properties of different nomenclature and legal groups. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology, organization of pharmaceutical business and forensic pharmacy". Kharkiv, 2013. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0066533.
Negretsky S.M. Forensic pharmaceutical substantiation of organizational measures to provide drugs for drug addicts addicted to cannabinoids (F12). Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology, organization of pharmaceutical business and forensic pharmacy". Kyiv, 2016. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0575291.
Shapovalov V.V. Forensic pharmaceutical bases of search of ways of pharmacocorrection of drug patients with deviant behavior within the limits of the state concept of counteraction to drug addiction and drug crime. Dissertation for Doctor of Pharmaceutical Sciences degree. Specialty 15.00.01 "Drug technology, organization of pharmaceutical business and forensic pharmacy". Kyiv, 2017. 44 p. URL: http://irbis-nbuv.gov.ua/ASUA/0089067.
Movsisyan A.G. Prevention of addictive dependence on the basis of forensic pharmacy in the formation of a healthy lifestyle among youth. Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology, organization of pharmaceutical business and forensic pharmacy". Kyiv, 2017. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/0695217.
Shuvera O.V. Forensic pharmaceutical bases of improvement of measures of counteraction at alcohol dependence (F 10.2). Dissertation for PhD in Pharmacy degree. Specialty 15.00.01 "Drug technology, organization of pharmaceutical business and forensic pharmacy". Kyiv, 2017. 24 p. URL: http://irbis-nbuv.gov.ua/ASUA/1256723.
ICD-11 for Mortality and Morbidity Statistics (Version: 05/2021). URL: https://icd.who.int/browse11/l-m/en.
Mendelevich V.D. The sick list on pedophilia and disability on drug addiction. Neurology Bulletin. 2017. Is. XLIX. No. 3 P. 5-10. URL: https://journals.eco-vector.com/1027-4898/article/view/14060.
Youmans K. Background & overview of ICD-11 before implementation in 2022. YES-him consulting. 18.10.2021.
URL: https://yes-himconsulting.com/icd-11-overview/
First M.B., Gaebel W., Maj M. еt al. An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5. Wiley Online Library. 12 January 2021. URL: https://doi.org/10.1002/wps.20825. DOI: https://doi.org/10.1002/wps.20825
Gutiérrez F., Peri J.M., Gárriz M. Integration of the ICD-11 and DSM-5 Dimensional Systems for Personality Disorders into a Unified Taxonomy with Non-overlapping Traits. Front. Psychiatry. 06 April 2021. URL: https://doi.org/10.3389/fpsyt.2021.591934. DOI: https://doi.org/10.3389/fpsyt.2021.591934
Paschke K., Austermann M.I., Thomasius R. ICD-11-Based Assessment of Social Media Use Disorder in Adolescents: Development and Validation of the Social Media Use Disorder Scale for Adolescents. Front. Psychiatry. 22.04.2021. URL: https://doi.org/10.3389/fpsyt.2021.661483. DOI: https://doi.org/10.3389/fpsyt.2021.661483
Korwisi B., Barke A., Rief W. еt al. Chronic pain in the 11th revision of the International Classification of Diseases users’ questions answered. PAIN. 03.12.2021. DOI: 10.1097/j.pain.0000000000002551. URL:https://journals.lww.com/pain/abstract/9000/classification_of_chronic_pain_for_the.98059.aspx DOI: https://doi.org/10.1097/j.pain.0000000000002551
Gatehouse S. ICD-11. Prep: Examining Prominent Changes in Preparation for the Transition. ICD10 monitor. URL: https://www.icd10monitor.com/icd-11-prep-examining-prominent-changes-in-preparation-for-the-transition.
Chen D., Zhang R., Zhao H., Feng J. A Bibliometric Analysis of the Development of ICD-11 in Medical Informatics. JHE. 2019. DOI: https://doi.org/10.1155/2019/1649363. DOI: https://doi.org/10.1155/2019/1649363
Tracy M., Tiliopoulos N., Sharpe L. The clinical utility of the ICD-11 classification of personality disorders and related traits: A preliminary scoping review. The Australian & New Zealand Journal of Psychiatry (ANZJP). Vol. 55. Issue 9. URL: https://doi.org/10.1177/00048674211025607. DOI: https://doi.org/10.1177/00048674211025607
ICD-11: an international classification of diseases for the twenty-first century/ Harrison J.E., Weber S., Jakob R. et al. BMC Med Inform Decis Mak 21, 206 (2021). URL: https://doi.org/10.1186/s12911-021-01534-6
Reed G.M., First M.B., Kogan C.S. еt al. Innovations and changes in the ICD-11 classification of mental, behavioral and neurodevelopmental disorders. Wiley Online Library. 02 January 2019. URL: https://doi.org/10.1002/wps.20611. DOI: https://doi.org/10.1002/wps.20611
Harrison J.E., Weber S., Jakob R. et al. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inform Decis Mak. 2021. N.21. 206 p. URL: https://doi.org/10.1186/s12911-021-01534-6. DOI: https://doi.org/10.1186/s12911-021-01534-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Viktoriia Shapovalova
This work is licensed under a Creative Commons Attribution 4.0 International License.
